Skip to main content

Table 3 Laryngeal endoscopic characters of studied groups

From: Vocal cordopathy consequent to bronchial asthma inhalation therapy

 Group A, habitual user, no = 65Group B, occasional user, no = 47P value
 Adult age (N = 55)Children age (N = 10)Adult age (N = 37)Children age (N = 10) 
Visual endoscopic findings
 After 6 months42 (76.3%)6 (60%)12 (32.4%)1 (10%) 
 End of study (total No)52 (94.5%)9 (90%)15 (40.5%)3 (30%)
1. Laryngeal edema and hyperemia
 After 6 months33 (60%)4 (40%)10 (27%)1 (10%)0.0032
 End of study (total No)37 (67.3%)5 (50%)12 (32.4%)2 (20%)
2. Laryngeal nodule/s
 After 6 months3 (5.4%)01 (2.7%)00.0021
 End of study (total No)5 (9%)1 (10%)1 (2.7%)0
3. Laryngeal polyp/s
 After 6 months1 (1.8%)000---------------
 End of study (total No)1 (1.8%)000
4. Cord paresis
 After 6 months1 (1.8%)0000.865
 End of study (total No)2 (3.6%)1 (10%)00
5. Vocal folds atrophy
 After 6 months1 (1.8%)000---------------
 End of study (total No)1 (1.8%)000
6. Vocal folds bowing
 After 6 months1 (1.8%)000---------------
 End of study (total No)1 (1.8%)000
7. Cord dysfunction
 After 6 months1 (1.8%)1 (10%)000.842
 End of study (total No)2 (3.6%)1 (10%)1 (2.7%)0
8. Plaques
 After 6 months1 (1.8%)1 (10%)1 (2.7%)00.754
 End of study (total No)2 (3.6%)2 (20%)2 (5.4%)1 (10%)
9. Glottis gap
 After 6 months0000---------------
 End of study (total no.)1 (1.8%)000